Erschienen in:
01.07.2004 | Experimental
Crystalloid strong ion difference determines metabolic acid–base change during acute normovolaemic haemodilution
verfasst von:
Thomas J. Morgan, Balasubramanian Venkatesh, Jonathan Hall
Erschienen in:
Intensive Care Medicine
|
Ausgabe 7/2004
Einloggen, um Zugang zu erhalten
Abstract
Objective
To study the acid–base effects of crystalloid strong ion difference (SID) during haemodilution.
Design
Prospective in vivo study.
Setting
University laboratory.
Subjects
Anaesthetised, mechanically ventilated Sprague-Dawley rats.
Interventions
Rats were studied in seven groups of three. Each group underwent normovolaemic haemodilution with one of seven crystalloids, with SID values from 0 to 40 mEq/l. Six exchanges of 9 ml crystalloid for 3 ml blood were performed.
Measurements and main results
[Hb] fell from 142±17 to 44±10 g/l (p<0.0001). Final plasma [lactate] was 1.1±0.6 mmol/l. Final standard base excess values ranged from −8 to +7 mmol/l, and were directly correlated with crystalloid SID (R2=0.91). By linear regression, the SID of a crystalloid balanced to maintain standard base excess=0 mmol/l was 23.7 mEq/l. Dilutions 2–5 produced similar results.
Conclusions
There is a linear relationship between crystalloid SID and post-dilutional metabolic acid–base status. The SID of a crystalloid balanced for normovolaemic haemodilution is 24 mEq/l. These principles are applicable in designing fluids for volume resuscitation, acute normovolaemic haemodilution and cardio-pulmonary bypass.